Researchers have developed a hydrogel composed of hyaluronic acid and hydroxyapatite nanoparticles that, in laboratory tests on rats, increased bone density by up to 4.8 times within 2-4 weeks when combined with systemic osteoporosis drugs.
This hydrogel specifically targets areas at high risk for fractures, offering potential to enhance recovery and complement existing therapies.
However, it's important to note that these findings are based on animal studies, and human clinical trials are pending to confirm efficacy and safety in humans.
コメント